Description
Cabergol 0.5 mg Tablet is a medication that effectively addresses hyperprolactinemic disorders by reducing elevated prolactin levels in the blood. It is also employed to halt lactation following childbirth, stillbirth, abortion, or miscarriage, and is suitable for women who opt not to breastfeed. The tablet is typically administered in divided doses over a week, with adjustments made based on the patient's response and prolactin levels. Common side effects may include nausea, dizziness, and fatigue. Patients with liver or kidney issues, or those with a history of psychiatric disorders, should use this medication with caution. As with all medications, it is essential to follow the prescribed dosage and consult a healthcare provider before starting or adjusting treatment.
.jpg)
Change Language